Latkin Jed 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed May 17, 2019
Insider Transaction Report
Form 4
Latkin Jed
Interim COO
Transactions
- Purchase
Common Stock
2019-05-16$1.45/sh+1,500$2,180→ 10,950 total - Purchase
Common Stock
2019-05-17$1.46/sh+1,000$1,463→ 11,950 total